|

- Drs. Lanteri, Lovallo, Ahmed & Esposito
Voted among Best Doctors in:
New York Magazine, New Jersey Monthly
and New York Metro Area.
Selected by:
Castle Connolly Top Doctors
for Cancer in America.
Gallo Award for Excellence in Clinical Cancer Research, 1999,
Cancer Institute of New Jersey; Prospective Phase I/II Trial of
Total Androgen Ablation, High Dose Rate Temporary Conformal Brachytherapy
and Conformal External Beam Radiotherapy for Locally Advanced,
High Risk Prostate Cancer.
Gallo Award for Excellence in Clinical Cancer Research, 2001,
Cancer Institute of New Jersey; Patterns and Predictors of Acute
Toxicity after HDR Brachytherapy and 3D-CRT for Localized Prostate
Cancer: Preliminary Results of Phase I-II Dose Escalation Study.
Prospective Study of Androgen Ablation, High Dose
Rate Temporary Conformal Brachytherapy and Conformal External Beam
Radiotherapy for Locally Advanced, Organ Confined, High Risk Prostate
Cancer, 82nd Annual Meeting of the American Radium Society, London,
England, April 2000.
Patterns and Predictors of Acute Toxicity after HDR
Brachytherapy and 3D-CRT for Localized Prostate Cancer: Preliminary
Results of Phase I-II Dose Escalation Study, 11th International
Prostate Cancer Update, Santa Fe, New Mexico, June 2001.
High Dose Intensity Modulated Radiotherapy (IMRT)
for Localized Prostate Cancer in a Community Practice: Preliminary
Results on Acute Toxicity and Quality of Life, 12th International
Prostate Cancer Update, Keystone, Colorado, February 2002.
Preliminary Analysis of the Accuracy of the VariSeed
Real-Time Dosimetric Optimization Program for Permanent Radioactive
Seed Implantation (PSI) of the Prostate: Real Time or Real Myth?,
12th International Prostate Cancer Update, Keystone, Colorado,
February 2002.
Patterns and Predictors of Acute Toxicity after HDR
Brachytherapy and 3D-CRT for Localized Prostate Cancer: Preliminary
Results of Phase I-II Dose Escalation Study, American Brachytherapy
Society Proceedings, Vancouver, British Columbia, Canada, May 2002.
Preliminary Analysis and First Report of the Accuracy
and Predictive Value of the VariSeed Real-Time Dosimetric Optimization
Program (Version 6.7) for Permanent Radioactive Seed Implantation
(PSI) of the Prostate, 88th Scientific Assembly and Annual Meeting
of the Radiology Society of North America, Chicago, Illinois, December
2002.
High Dose Intensity Modulated Radiotherapy (IMRT)
for Localized Prostate Cancer in a Community Practice: Preliminary
Results on Acute Toxicity and Quality of Life, 88th Scientific
Assembly and Annual Meeting of the Radiology Society of North America,
Chicago, Illinois, December 2002.
Comparison of real-time US implantation of the prostate
using a look-up nomogram versus US assisted implantation using
the VariSeed Optimization Program: improved target coverage with
reduced urethral and rectal dose, 24th Annual Meeting of the American
Brachytherapy Society, New York, New York, May 2003.
Preliminary Analysis and First Report of the Accuracy
and Predictive Value of the VariSeed Real-Time Dosimetric Optimization
Program (Version 6.7) for Permanent Radioactive Seed Implantation
(PSI) of the Prostate, 11th International Prostate Cancer Update,
Santa Fe, New Mexico, June 2001.
Acute and Late Morbidity, and Preliminary Biochemical
Control After Combined Androgen Blockade, High Dose Rate Brachytherapy
and 3D-Conformal Radiotherapy: Follow-up Results of a Prospective
Phase I/II Dose Escalation Trial, 21st Annual Estro Meeting, Prague,
Czechoslovakia, September 2002.
Feasibility and Safety of High Dose Intensity Modulated
Radiotherapy (IMRT) for Localized Prostate Cancer in a Community
Practice: Preliminary Results on Acute Toxicity, 21st Annual Estro
Meeting, Prague, Czechoslovakia, September 2002.
Preliminary Analysis and First Report of the Accuracy
and Predictive Value of the VariSeed Real-Time Dosimetric Optimization
Program (Version 6.7) for Permanent Radioactive Seed Implantation
(PSI) of the Prostate, 21st Annual Estro Meeting, Prague, Czechoslovakia,
September 2002.

January, 2007
Jeffrey Stock
Michael Esposito
Vincent Lanteri
Patterns and Predictors of Acute Toxicity after HDR
Brachytherapy and 3D-CRT for Localized Prostate Cancer: Preliminary
Results of Phase I-II Dose Escalation Study, A. Raben, MD, J.Geltzeiler,
A.Grebler, MD, S.Litvin, MD, I.Keselman, MD, Journal of Brachytherapy
International, Vol. 17, #2, April – June 2002.
Analysis and First Report of the Accuracy and Predictive
Value of the VariSeed Real-Time Dosimetric Optimization Program
(Version 6.7) for Permanent Radioactive Seed Implantation (PSI)
of the Prostate, A. Raben, MD, J. Geltzeiler, MD, A.Grebler, MD,
S.Litvin, MD, I.Keselman, MD, Radiotherapy & Oncology, Vol.
64, Supplement 1, September 2002.
Comparison of real-time US implantation of the prostate
using a look-up nomogram versus US assisted implantation using
the VariSeed Optimization Program: improved target coverage with
reduced urethral and rectal dose, A. Raben, H. Chen, et al, Brachytherapy,
Vol. 2, #1, May 2003.
[ top ]
|
|
|
Urological Surgery
|
|
| |
|
 |
 |
|